Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label imatinib study in PDGFRA-expressing peripheral T-cell lymphoma
2006-002658-31Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in peripheral T-cell lymphoma (PTCL), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Clinical response rate. Started Mar 2007; status: completed.
02
Drugs
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on 2006-002658-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002658-31.